Cardlytics, Inc. — Director's Dealing 2019

Mar 21, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2019-03-19

Reporting Person: Evans David Thomas (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-19	Common Stock	S	864	$15.68	Disposed	47005	Direct
2019-03-20	Common Stock	S	870	$15.56	Disposed	46135	Direct
2019-03-21	Common Stock	S	850	$15.92	Disposed	45285	Direct

Footnotes

F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018.

F2: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.61 to $15.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

F3: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.56 to $15.63, inclusive.

F4: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.89 to $16.0901, inclusive.